The Institute for Neurophysiopathology spinout has completed a series D round.
Vect-Horus, a France-based biotechnology developer spun out of Institute for Neurophysiopathology, has completed a €12m ($14.5m) series D round featuring undisclosed backers.
Vect-Horus is working on vectors that enable therapeutic molecules or imaging agents to be delivered to key organs. The money has been allocated to existing programmes, the development of additional vectors and technology validation.
The company emerged out of Institute for Neurophysiopathology, a joint research institute of Aix Marseille University and CNRS. It was founded in…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
